These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30346265)

  • 21. Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure.
    Zhang FT; Wan HJ; Li MH; Ye J; Yin MJ; Huang CQ; Yu J
    World J Gastroenterol; 2011 Feb; 17(7):938-45. PubMed ID: 21412504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.
    Bassiouny AR; Zaky AZ; Abdulmalek SA; Kandeel KM; Ismail A; Moftah M
    Int J Clin Exp Pathol; 2011; 4(7):692-707. PubMed ID: 22076170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo-expanded bone marrow stem cells home to the liver and ameliorate functional recovery in a mouse model of acute hepatic injury.
    Jin SZ; Liu BR; Xu J; Gao FL; Hu ZJ; Wang XH; Pei FH; Hong Y; Hu HY; Han MZ
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):66-73. PubMed ID: 22251472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of CCl
    Yokoyama T; Yagi Mendoza H; Tanaka T; Ii H; Takano R; Yaegaki K; Ishikawa H
    Hum Cell; 2019 Apr; 32(2):125-140. PubMed ID: 30637566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models.
    Kamel MM; Baz HGE; Demerdash Z; Hassan S; Salah F; Mansour WA; Hammam O; Atta S; Bayoumi A; Hassan M; Mahmoud S
    Adv Clin Exp Med; 2018 Oct; 27(10):1329-1339. PubMed ID: 30048056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Yiguanjian decoction on cell differentiation and proliferation in CCl₄-treated mice.
    Wang XL; Jia DW; Liu HY; Yan XF; Ye TJ; Hu XD; Li BQ; Chen YL; Liu P
    World J Gastroenterol; 2012 Jul; 18(25):3235-49. PubMed ID: 22783047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion and Hepatic Differentiation of Adult Blood-Derived CD34+ Progenitor Cells and Promotion of Liver Regeneration After Acute Injury.
    Hu M; Li S; Menon S; Liu B; Hu MS; Longaker MT; Lorenz HP
    Stem Cells Transl Med; 2016 Jun; 5(6):723-32. PubMed ID: 27075766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Kuo TK; Hung SP; Chuang CH; Chen CT; Shih YR; Fang SC; Yang VW; Lee OK
    Gastroenterology; 2008 Jun; 134(7):2111-21, 2121.e1-3. PubMed ID: 18455168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.
    Liu L; Yannam GR; Nishikawa T; Yamamoto T; Basma H; Ito R; Nagaya M; Dutta-Moscato J; Stolz DB; Duan F; Kaestner KH; Vodovotz Y; Soto-Gutierrez A; Fox IJ
    Hepatology; 2012 May; 55(5):1529-39. PubMed ID: 22109844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte-like Versus Mesenchymal Stem Cells in CCl4-induced Liver Fibrosis.
    Ewida SF; Abdou AG; El-Rasol Elhosary AA; El-Ghane Metawe SA
    Appl Immunohistochem Mol Morphol; 2017; 25(10):736-745. PubMed ID: 27153445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.
    Campard D; Lysy PA; Najimi M; Sokal EM
    Gastroenterology; 2008 Mar; 134(3):833-48. PubMed ID: 18243183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver fibrosis protects mice from acute hepatocellular injury.
    Bourbonnais E; Raymond VA; Ethier C; Nguyen BN; El-Leil MS; Meloche S; Bilodeau M
    Gastroenterology; 2012 Jan; 142(1):130-139.e4. PubMed ID: 21945831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous bone marrow cell infusion therapy for liver cirrhosis.
    Sakaida I
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1349-53. PubMed ID: 18422964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal application of human unrestricted somatic stem cells to support hepatic regeneration after portal embolization and tumor surgery.
    Ghodsizad A; Fahy BN; Waclawczyk S; Liedtke S; Gonzalez Berjon JM; Barrios R; Mehrabi A; Karck M; Ruhparwar A; Kögler G
    ASAIO J; 2012; 58(3):255-61. PubMed ID: 22543756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Potential of Bama Pig Adipose-Derived Mesenchymal Stem Cells for the Treatment of Carbon Tetrachloride-Induced Liver Fibrosis.
    Wu X; Zhang S; Lai J; Lu H; Sun Y; Guan W
    Exp Clin Transplant; 2020 Dec; 18(7):823-831. PubMed ID: 33349209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal Stem Cells with Enhanced Bcl-2 Expression Promote Liver Recovery in a Rat Model of Hepatic Cirrhosis.
    Jin S; Li H; Han M; Ruan M; Liu Z; Zhang F; Zhang C; Choi Y; Liu B
    Cell Physiol Biochem; 2016; 40(5):1117-1128. PubMed ID: 27960154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model.
    Jung KH; Shin HP; Lee S; Lim YJ; Hwang SH; Han H; Park HK; Chung JH; Yim SV
    Liver Int; 2009 Jul; 29(6):898-909. PubMed ID: 19422480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DIFFERENTIATION OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS INTO HEPATOCYTES INDUCED BY RAT FIBROTIC LIVER TISSUE EXTRACTS].
    Yan C; Xue G; Wu L; Liu J; Hou Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):878-83. PubMed ID: 26540984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis.
    Ren H; Zhao Q; Cheng T; Lu S; Chen Z; Meng L; Zhu X; Yang S; Xing W; Xiao Y; Ren Q; Chi Y; Gu D; Yang R; Han ZC
    Cytotherapy; 2010 May; 12(3):371-83. PubMed ID: 20184502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional hepatic recovery after xenotransplantation of cryopreserved fetal liver cells or soluble cell-factor administration in a cirrhotic rat model: are viable cells necessary?
    Ochenashko OV; Nikitchenko YV; Volkova NA; Mazur SP; Somov AY; Fuller BJ; Petrenko AY
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e275-82. PubMed ID: 17725601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.